🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of 4 doses o...
Status
Completed
Location
Multiple Locations
Start Date
2003-12
Trial ID
NCT00421031
Treatments Being Tested
The main objective of this study is to compare the antidepressant efficacy ...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00092911
Treatments Being Tested
To compare the antidepressant efficacy and safety of DVS-233 SR with those ...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00090649
Treatments Being Tested
To evaluate the long-term safety of desvenlafaxine sustained release (DVS-2...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT00452595
Treatments Being Tested
To determine the bioequivalence of 2 tablets of 25 mg sustained release (SR...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-09
Trial ID
NCT01190514
Primary Objective: To compare the antidepressant efficacy and safety of sub...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00073762
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of desvenlaf...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00256685
Treatments Being Tested
Primary: To assess the efficacy and safety of DVS-233 SR compared with plac...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00195546
Treatments Being Tested
The goal of this study is to evaluate the effect of multiple doses of Desve...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-08
Trial ID
NCT01188668
Treatments Being Tested
The primary objective of this study is to evaluate the long-term safety of ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-03
Trial ID
NCT00831415
Treatments Being Tested